These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 26040586)
1. Evaluation of multiple comparison correction procedures in drug assessment studies using LORETA maps. Alonso JF; Romero S; Mañanas MÁ; Rojas M; Riba J; Barbanoj MJ Med Biol Eng Comput; 2015 Oct; 53(10):1011-23. PubMed ID: 26040586 [TBL] [Abstract][Full Text] [Related]
2. Double-blind, placebo-controlled, multiple-ascending-dose study on the pharmacodynamics of ABIO-08/01, a new CNS drug with potential anxiolytic activity. 2. EEG-tomography findings based on LORETA (low-resolution brain electromagnetic tomography). Saletu B; Anderer P; Wolzt M; Nosiska D; Assandri A; Noseda E; Nannipieri F; Saletu-Zyhlarz GM Neuropsychobiology; 2009; 59(2):110-22. PubMed ID: 19365151 [TBL] [Abstract][Full Text] [Related]
3. EEG topography and tomography (LORETA) in the classification and evaluation of the pharmacodynamics of psychotropic drugs. Saletu B; Anderer P; Saletu-Zyhlarz GM Clin EEG Neurosci; 2006 Apr; 37(2):66-80. PubMed ID: 16733939 [TBL] [Abstract][Full Text] [Related]
4. Classification and evaluation of the pharmacodynamics of psychotropic drugs by single-lead pharmaco-EEG, EEG mapping and tomography (LORETA). Saletu B; Anderer P; Saletu-Zyhlarz GM; Arnold O; Pascual-Marqui RD Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():97-120. PubMed ID: 12575493 [TBL] [Abstract][Full Text] [Related]
5. Influence of ocular filtering in EEG data on the assessment of drug-induced effects on the brain. Romero S; Mañanas MA; Barbanoj MJ Hum Brain Mapp; 2009 May; 30(5):1470-80. PubMed ID: 18548559 [TBL] [Abstract][Full Text] [Related]
6. Reliability of quantitative EEG (qEEG) measures and LORETA current source density at 30 days. Cannon RL; Baldwin DR; Shaw TL; Diloreto DJ; Phillips SM; Scruggs AM; Riehl TC Neurosci Lett; 2012 Jun; 518(1):27-31. PubMed ID: 22575610 [TBL] [Abstract][Full Text] [Related]
7. Cross-conditional entropy and coherence analysis of pharmaco-EEG changes induced by alprazolam. Alonso JF; Mañanas MA; Romero S; Rojas-Martínez M; Riba J Psychopharmacology (Berl); 2012 Jun; 221(3):397-406. PubMed ID: 22127555 [TBL] [Abstract][Full Text] [Related]
8. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration. Saletu B; Grünberger J; Anderer P; Linzmayer L; König P Arzneimittelforschung; 1995 Mar; 45(3):217-29. PubMed ID: 7741773 [TBL] [Abstract][Full Text] [Related]
9. Pharmaco-EEG Studies in Animals: A History-Based Introduction to Contemporary Translational Applications. Drinkenburg WH; Ahnaou A; Ruigt GS Neuropsychobiology; 2015; 72(3-4):139-50. PubMed ID: 26901675 [TBL] [Abstract][Full Text] [Related]
10. Connectivity analysis of EEG under drug therapy. Alonso JF; Mañanas MA; Romero S; Riba J; Barbanoj MJ; Hoyer D Annu Int Conf IEEE Eng Med Biol Soc; 2007; 2007():6188-91. PubMed ID: 18003434 [TBL] [Abstract][Full Text] [Related]
11. Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy. Saletu M; Anderer P; Semlitsch HV; Saletu-Zyhlarz GM; Mandl M; Zeitlhofer J; Saletu B Psychiatry Res; 2007 Jan; 154(1):69-84. PubMed ID: 17187965 [TBL] [Abstract][Full Text] [Related]
12. Electrophysiological neuroimaging of the central effects of S-adenosyl-L-methionine by mapping of electroencephalograms and event-related potentials and low-resolution brain electromagnetic tomography. Saletu B; Anderer P; Di Padova C; Assandri A; Saletu-Zyhlarz GM Am J Clin Nutr; 2002 Nov; 76(5):1162S-71S. PubMed ID: 12418497 [TBL] [Abstract][Full Text] [Related]
14. EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil. Saletu M; Anderer P; Saletu-Zyhlarz GM; Mandl M; Arnold O; Zeitlhofer J; Saletu B J Neurol; 2004 Nov; 251(11):1354-63. PubMed ID: 15592731 [TBL] [Abstract][Full Text] [Related]
15. EEG topography and tomography (LORETA) in diagnosis and pharmacotherapy of depression. Saletu B; Anderer P; Saletu-Zyhlarz GM Clin EEG Neurosci; 2010 Oct; 41(4):203-10. PubMed ID: 21077572 [TBL] [Abstract][Full Text] [Related]
17. A recursive algorithm for the three-dimensional imaging of brain electric activity: Shrinking LORETA-FOCUSS. Liu H; Gao X; Schimpf PH; Yang F; Gao S IEEE Trans Biomed Eng; 2004 Oct; 51(10):1794-802. PubMed ID: 15490826 [TBL] [Abstract][Full Text] [Related]
18. EEG topography and tomography in diagnosis and treatment of mental disorders: evidence for a key-lock principle. Saletu B; Anderer P; Saletu-Zyhlarz GM; Pascual-Marqui RD Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():97-106. PubMed ID: 12575475 [TBL] [Abstract][Full Text] [Related]
19. Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: I. Double-blind, placebo-controlled EEG mapping and psychometric studies under normoxia. Saletu B; Grünberger J; Anderer P; Linzmayer L Methods Find Exp Clin Pharmacol; 1996; 18(1):55-66. PubMed ID: 8721257 [TBL] [Abstract][Full Text] [Related]
20. Integration of EEG source imaging and fMRI during continuous viewing of natural movies. Whittingstall K; Bartels A; Singh V; Kwon S; Logothetis NK Magn Reson Imaging; 2010 Oct; 28(8):1135-42. PubMed ID: 20579829 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]